The pharma industry has called the IRA “price setting” and argues that the negotiations have not cut out-of-pocket costs for ...

Novo Nordisk launches Ozempic in India, outlining prices, doses, and its bid to capture rising diabetes and weight-loss ...

The maker of the blockbuster weight loss and diabetes drugs Wegovy and Ozempic have cut the prices for most versions of these medications. Novo Nordisk dropped the price for injectable Wegovy and ...

The ‘Botched’ star said that weight loss can make the penis look bigger. “So congratulations," he tells men taking the GLP-1 Gilbert Flores/Variety via Getty Dr. Terry Dubrow shared the unexpected ...

Novo Nordisk on Monday lowered the direct-to-consumer prices of its weight loss drug Wegovy and diabetes treatment Ozempic in a challenge to Eli Lilly’s Zepbound after President Donald Trump announced ...

Lizzo believes we, as a society, must “undo the effects of the Ozempic boom” because plus-sized women are being “erased.” The musician, 37, took to Substack on Sunday to share an essay titled, “Why is ...

For a limited time, patients can get a steep discount on the popular medications, as long as they’re paying out of pocket Steve Christo/Corbis/Corbis/Getty Ozempic ...

The costs for Ozempic and Wegovy injections are being reduced in a limited-time four-month deal, Novo Nordisk announced on Monday. The introductory price applies only to the lowest strength injections ...

GLP-1 weight loss drugs are still far from cheap, but some of the prices keep dropping. Novo Nordisk is now offering people who pay out of pocket a steep discount for select doses of Ozempic and ...

Kirstyn Hill has worked as a clinical pediatric and women’s health pharmacist since 2020. She was driven to work with a patient population that is not often able to easily speak up for themselves and ...

Standard workplace drug tests are unlikely to detect Ozempic, since semaglutide controlled substances. While routine urine tests usually don’t reveal Ozempic, specialized blood tests can detect the ...

Novo Nordisk A/S is undercutting archrival Eli Lilly & Co. on obesity drugs for cash-pay patients, showing its willingness to compete on price as it tries to claw back a larger share of the U.S.